key: cord-0917881-jjdaprtu
authors: Srinivasan, Mythily; Zunt, Susan L; Goldblatt, Lawrence I
title: Oral epithelial expression of angiotensin converting enzyme-2: Implications for COVID-19 diagnosis and prognosis
date: 2020-06-23
journal: bioRxiv
DOI: 10.1101/2020.06.22.165035
sha: 38c10772960d2f4b4a34333221e7afdddba29506
doc_id: 917881
cord_uid: jjdaprtu

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) uses the angiotensin converting enzyme (ACE)-2 as the host receptor for target cell entry. The extent and distribution of ACE-2 has been associated with the clinical symptoms of coronavirus disease (COVID)-19. Here we show by immunofluorescence analysis that the ACE2 is abundantly expressed in oral mucosa, particularly in the surface epithelial cells suggesting that these cells could represent sites of entry for SARS-CoV-2. Further, together with the reports on ACE2 ectodomain shedding, we discuss the rationale for the hypothesis that the ACE-2 measurement in saliva could be a marker for COVID-19 infection during early phase following SARS-CoV-2 exposure.

Coronaviruses (CoV) are a group of enveloped viruses with non-segmented, single-stranded, and positive sense RNA genomes. While most coronaviruses cause mild respiratory illnesses, the first epidemic was caused by the severe acute respiratory syndrome (SARS)-CoV-1 in 2003.

SARS-CoV-1 spread to over two dozen countries affecting more than 8000 individuals with nearly 10% mortality 1,2 . The current pandemic caused by SARS CoV-2 has spread much more rapidly affecting nearly 7 million individuals globally with over 400,000 deaths as of June 2020.

Both SARS-CoVs encode at least four major structural proteins including the spike protein, the membrane protein, the envelope protein, and the nucleocapsid protein. The spike protein that protrudes from the surface of the virus is a type I glycoprotein that binds specific host cell receptor via a receptor binding domain facilitating viral entry into target cells 3 . The SARS-CoV-1 has been shown to use a metallopeptidase named angiotensin-converting enzyme 2 (ACE2) as a receptor for target cell entry 4, 5 . Positive correlation between ACE2 expression and SARS-CoV-1 infection has been observed 6 . Furthermore, ACE2 expression on non-permissive cells conferred susceptibility to SARS-CoV-1 infection, indicating that ACE2 is sufficient to allow viral entry 7, 8 . Transgenic mice overexpressing human ACE2 in alveolar epithelial cells and other epithelia developed rapidly progressing respiratory illness following intranasal exposure of SARS-CoV-1 9 .

Genomic and structural studies have shown that the receptor binding domain of SARS-CoV-2 exhibits similar molecular characteristics as that of SARS-CoV-1 10, 11 . In vitro cellular studies showed that that the SARS-CoV-2 used ACE2 and no other coronavirus receptors such as aminopeptidase for cellular entry 11 . Indeed SARS-CoV-2 has been shown to bind ACE2 with higher affinity than the SARS-CoV-1 12 . Upon binding ACE2, the spike protein of SARS-CoV-2 is cleaved by host proteases such as the TMPRSS2, thereby releasing the spike fusion peptide and facilitating host cell entry 10, 13 . Replication within the target cells establishes the SARS-CoV-2 infection mediating tissue damage. ACE2 is mainly expressed by epithelial cells of the lung, intestine, kidney, and colon (3). This may explain the high incidence of pneumonia and bronchitis in those with severe COVID-19 infection 5, 14 . Analyses of the publicly available RNA data sets and immunohistochemical studies suggest that the ACE2 is also highly expressed in the skin and mucous membranes including the oral mucosa [15] [16] [17] . Consistently, vesiculobullous lesions affecting the skin and the oral mucosa have been reported as clinical presentations in COVID-19 18, 19 . Since the viral attachment and entry is critical for replication and infection, the state of cell differentiation and the surface expression of ACE2 can directly influence the SARS-CoV disease pathogenesis.

Hence, the goal of this study is to investigate the localization of ACE2 in mucosa from different regions of the oral cavity.

Tissues: Archived paraffin embedded tissue blocks of buccal mucosa and tongue tissues with histological diagnosis of benign mucosal lesions such as fibroma and papilloma were obtained from the repository of the Oral Pathology Biopsy services at the Indiana University School of Dentistry. Hematoxylin and eosin stained sections were evaluated for the presence of sufficient amount of normal oral epithelium adjacent to the lesion in each tissue. Only tissues that possessed significant normal oral epithelium with no evidence of pathology were included for assessment of ACE2 expression.

Isolation of epithelial cells in saliva: Unstimulated whole saliva was collected by the drooling method for 5-10 minutes into a 15ml chilled centrifuge tube after obtaining informed consent as described 20, 21 . All samples were centrifuged at 250g for 10 minutes at 4C. The cellular sediment obtained was reconstituted in isotonic saline supplemented with two drops of Zap-O globin to lyse blood corpuscles and centrifuged at 1400rpm for 10min at 4C. After washing in saline, the cell suspension was passed through a 20µ filter. The epithelial cell-enriched preparation was then assessed by light microscope for morphology. A thin smear of the cells was then maintained in a humid chamber and immunostained for ACE-2 along with the tissue section.

Immunofluorescence: The paraffin-embedded sections were dewaxed and rehydrated by sequential incubation in decreasing alcohol concentrations. The sections were then subjected to heat induced antigen retrieval in Tris-EDTA buffer for 10 minutes. The slides were allowed to cool, washed with 1XTBS buffer and then incubated with 3% H2O2 for 10min to quench endogenous peroxidase activity followed by washing and incubation in 5% goat anti-serum to minimize non-specific binding. The sections were then incubated with the primary anti-human 

Membrane bound ACE2 is the port of entry for SARS-CoVs to the target cells. ACE2 transcript and protein expression has been reported in several human tissues by reverse transcriptase polymerase chain reaction and immunohistochemistry respectively 5, 14, 16 . We observed strong ACE2 expression in the epithelial cells of the oral mucosa. The expression was higher in the keratinized surface epithelial cells than in the spinous or basal cells. This was more evident in the tongue tissues than that of the buccal mucosa (Fig 1A, D) . Merged images with the nuclei staining propidium iodide (Fig 1B, E) showed prominent expression of ACE2 localized to the cell membranes (Fig 1C, F) . The exfoliated epithelial cells in the saliva also exhibited significant ACE2 expression (Fig 2A) . Merged images with nuclei staining propidium iodide (Fig 2B) shows that ACE-2 expression is observed on the membranes of the epithelial cells in saliva (Fig 2C) .

Epithelia are the primary barrier to microbial infection transmitted by contact with the exposed environment. As such, the epithelial cells express cell surface receptors that allow attachment to and penetration of the cell membrane by the microbes 20 Structurally, ACE2 is a type I transmembrane protein with a short C-terminal cytoplasmic tail, a hydrophobic transmembrane region, and a glycosylated amino terminal ectodomain containing the active site 4, 5 . A soluble form of ACE2 (sACE2) has been shown to be released either constitutively or induced by inflammation. The sACE2 arises from proteolytic cleavage of the ectodomain of the membrane bound ACE2 by the metalloproteinase ADAM-17, also known as TNF-α converting enzyme (TACE) 25 . Circulating levels of sACE2 has been shown to be low in children of both sexes, but increases with age, more so in healthy males than in females, so that as adults serum sACE2 is higher in men than in women 26 .

In-vitro studies and animal experiments have shown critical roles for both membrane-bound ACE2 and sACE2 in the acute lung injury mediated by SARS-CoV 27 . The SARS-CoV spike protein not only binds the cell surface ACE2 but also has been shown to induce cleavage of ACE2 ectodomain together with the host protease TACE to achieve target cell entry 25 . The ACE2 shedding induced by the spike protein is tightly associated with the TNF-α production.

Silencing of TACE with siRNA prevented viral entry suggesting that the SARS-spike protein induced TNF-α secretion and consequent TACE mediated ACE2 shedding is critical for infection 28 . Indeed, sACE2 has been suggested as a prognostic marker for SARS-CoV2 infection 29 .

In this context, our observation of ACE2 in the epithelial cells in saliva can be extended hypothetically as a potential marker for SARS-CoV-2 infection. It is likely that the surface epithelial cells of the oral mucosa that exhibit high expression of ACE2 act as initial sites of SARS-CoV-2 entry. Either the TNF-α induced by the viral attachment and/or released by the mild state of inflammation of the oral mucosa in health, may facilitate the SARS-spike protein mediated shedding of ACE2. Longitudinal observations in few SARS-CoV-2 positive cases have shown that the viral load in saliva was consistently higher during the symptomatic phase [30] [31] [32] . It is likely that the persistent infection could increase ACE2 ectodomain shedding from oral epithelial cells. Collectively, it can be postulated that the ACE2 levels in saliva could correlate with the SARS-CoV-2 viral load and potentially be predictive of symptom development in COVID-19 (Fig 3) .

In a review of over 700 publications on diagnostic approaches of viral infections, the authors observed that the application of non-invasive sampling methods such as the use of saliva for diagnosis and monitoring of viral diseases need to be widely investigated 33 . This is particularly critical for respiratory infections such as SARS-CoV-2, in which the viral load in saliva has been shown to be higher in early phase of the disease 31, 32, 34 . Based on our histological observations and the rationale discussed, we postulate that the assessment of SARS-CoV-2 viral load and ACE2 in the saliva could represent potential biomarkers for COVID-19 diagnosis and prognosis.

Human Coronavirus: Host-Pathogen Interaction

Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV

Spike protein recognition of mammalian ACE2 predicts the host range and an optimized ACE2 for SARS-CoV-2 infection

Structure of SARS coronavirus spike receptorbinding domain complexed with receptor

Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia

Exogenous ACE2 expression allows refractory cell lines to support severe acute respiratory syndrome coronavirus replication

COVID-19 preclinical models: human angiotensinconverting enzyme 2 transgenic mice

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

A pneumonia outbreak associated with a new coronavirus of probable bat origin

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research

Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis

Severe acute respiratory syndrome coronavirus on hospital surfaces

Single-cell RNA expression profiling of ACE2, the putative receptor of Wuhan 2019-nCoV

High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa

Cutaneous manifestations in COVID-19: a new contribution

Oral vesiculobullous lesions associated with SARS-CoV-2 infection

Differential profiles of soluble and cellular toll like receptor (TLR)-2 and 4 in chronic periodontitis

Quality assessment of saliva bank samples

Role of salivary epithelial toll-like receptors 2 and 4 in modulating innate immune responses in chronic periodontitis

Severe acute respiratory syndrome coronavirus infection of human ciliated airway epithelia: role of ciliated cells in viral spread in the conducting airways of the lungs

High expression of ACE2 on the keratinocytes reveals skin as a potential target for SARS-CoV-2

Modulation of TNF-alpha-converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF-alpha production and facilitates viral entry

COVID-19 Infection and Circulating ACE2 Levels: Protective Role in Women and Children

The pivotal link between ACE2 deficiency and SARS-CoV-2 infection

TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

Additional molecular testing of saliva specimens improves the detection of respiratory viruses

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. medRxiv

Find the right sample: A study on the versatility of saliva and urine samples for the diagnosis of emerging viruses

Asymptomatic Infection